The distribution at each timepoint of interest suggests uptitration to the 1.5 mg dosage formulation among Italian incident users, with dosage increase to the 3.0 mg or 4.5 mg formulations (which were not available in Italy) in France, 16% and 5% respectively
Do not take Rybelsus if you: Are allergic to semaglutide or any other ingredients in the medication Are pregnant or breastfeeding Have medullary thyroid cancer (MTC) Have multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Before taking Rybelsus, inform your doctor if you: Are pregnant or breastfeeding Ever had pancreatitis Have medullary thyroid cancer (MTC) or multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Have type 1 diabetes, develop ketoacidosis (increased ketones in blood or urine) Have a high heart rate Have end-stage renal disease or liver disease Have diabetic retinopathy Have digestive problems like vomiting, diarrhea or dehydration Drug interactions Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines
B12 overdose symptoms include skin rashes, itching, upset stomach (nausea, vomiting, diarrhea), b12 overdose headache, and feeling anxious or nervous
Indications and Use: Compounded semaglutide is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off
